Clinical trial
Irradiation Stent Placement Plus Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: A Multicenter Randomized Study
NCT03730675 is registered in ClinicalTrials.gov with Zhongda Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Irradiation Stent Placement Plus Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: A Multicenter Randomized Study
- Lead sponsor
- Zhongda Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 10, 2018
- Completion date
- November 10, 2021
- Enrollment
- 308 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma, portal vein tumor thrombosis